Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.82+0.05 (+0.74%)
Close on Nov 17, 2026Market cap $445.93MP/E 42.6Yield –
Arvinas profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Arvinas's profit margin for the twelve months ending Jun 30, 2026 was 2.9%. For fiscal 2025 it was -30.8%, against -75.5% the year before. The highest annual figure on record is -30.8% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -30.8% | +44.7 |
| FY2024 | Dec 31, 2024 | -75.5% | +392.4 |
| FY2023 | Dec 31, 2023 | -467.9% | −252.9 |
| FY2022 | Dec 31, 2022 | -215.0% | +141.4 |
| FY2021 | Dec 31, 2021 | -356.3% | +104.3 |
| FY2020 | Dec 31, 2020 | -460.6% | −297.1 |
| FY2019 | Dec 31, 2019 | -163.5% | +126.1 |
| FY2018 | Dec 31, 2018 | -289.6% | +27.7 |
| FY2017 | Dec 31, 2017 | -317.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 67.8% | +341.1 |
| Q1 FY2026 | Mar 31, 2026 | -369.2% | −413.1 |
| Q4 FY2025 | Dec 31, 2025 | -709.5% | −633.3 |
| Q3 FY2025 | Sep 30, 2025 | -83.8% | −35.7 |
| Q2 FY2025 | Jun 30, 2025 | -273.2% | −227.2 |
| Q1 FY2025 | Mar 31, 2025 | 43.9% | +318.2 |
| Q4 FY2024 | Dec 31, 2024 | -76.2% | +108.8 |
| Q3 FY2024 | Sep 30, 2024 | -48.0% | +74.2 |
| Q2 FY2024 | Jun 30, 2024 | -46.0% | +206.0 |
| Q1 FY2024 | Mar 31, 2024 | -274.3% | −55.0 |
| Q3 FY2023 | Sep 30, 2023 | -185.0% | +14.4 |
| Q2 FY2023 | Jun 30, 2023 | -122.2% | +84.9 |
| Q1 FY2023 | Mar 31, 2023 | -252.0% | −12.8 |
| Q4 FY2022 | Dec 31, 2022 | -219.3% | −59.7 |
| Q3 FY2022 | Sep 30, 2022 | -199.4% | +303.8 |
| Q2 FY2022 | Jun 30, 2022 | -207.1% | +707.4 |
| Q1 FY2022 | Mar 31, 2022 | -239.2% | +506.2 |
| Q4 FY2021 | Dec 31, 2021 | -159.6% | +497.7 |
| Q3 FY2021 | Sep 30, 2021 | -503.2% | −97.5 |
| Q2 FY2021 | Jun 30, 2021 | -914.5% | −475.6 |
| Q1 FY2021 | Mar 31, 2021 | -745.5% | −397.0 |
| Q4 FY2020 | Dec 31, 2020 | -657.3% | −227.2 |
| Q3 FY2020 | Sep 30, 2020 | -405.7% | −346.9 |
| Q2 FY2020 | Jun 30, 2020 | -438.9% | −11.5 |
| Q1 FY2020 | Mar 31, 2020 | -348.4% | +10.2 |
| Q4 FY2019 | Dec 31, 2019 | -430.1% | +37.5 |
| Q3 FY2019 | Sep 30, 2019 | -58.8% | +337.8 |
| Q2 FY2019 | Jun 30, 2019 | -427.4% | −196.3 |
| Q1 FY2019 | Mar 31, 2019 | -358.6% | −257.6 |
| Q4 FY2018 | Dec 31, 2018 | -467.6% | −283.8 |
| Q3 FY2018 | Sep 30, 2018 | -396.6% | −13.3 |
| Q2 FY2018 | Jun 30, 2018 | -231.0% | +169.1 |
| Q1 FY2018 | Mar 31, 2018 | -101.0% | +273.2 |
| Q4 FY2017 | Dec 31, 2017 | -183.8% | – |
| Q3 FY2017 | Sep 30, 2017 | -383.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -400.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -374.3% | – |
See a number that looks wrong?